Citigroup gives a Buy recommendation for Neurocrine Biosciences, Inc (NBIX)

Samantha Gray

In a filing, Neurocrine Biosciences, Inc revealed its Director RASTETTER WILLIAM H unloaded Company’s shares for reported $2.73 million on Nov 05 ’25. In the deal valued at $151.82 per share,18,000 shares were sold. As a result of this transaction, RASTETTER WILLIAM H now holds 40,360 shares worth roughly $5.94 million.

Then, Gano Kyle bought 300 shares, generating $42,591 in total proceeds.

Before that, WILLIAM H. RASTETTER bought 18,000 shares. Neurocrine Biosciences, Inc shares valued at $2,577,420 were divested by the Director at a price of $143.19 per share.

Citigroup initiated its Neurocrine Biosciences, Inc [NBIX] rating to a Buy in a research note published on October 21, 2025; the price target was $175. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. Goldman began covering NBIX with “Buy” recommendation on July 10, 2025. Needham revised its rating on April 15, 2025. It rated NBIX as “a Buy” which previously was an “a Hold”.

Price Performance Review of NBIX

On Tuesday, Neurocrine Biosciences, Inc [NASDAQ:NBIX] saw its stock fall -1.82% to $147.29. Over the last five days, the stock has gained 2.86%. Neurocrine Biosciences, Inc shares have risen nearly 18.80% since the year began. Nevertheless, the stocks have risen 7.90% over the past one year. While a 52-week high of $157.67 was reached on 11/05/25, a 52-week low of $84.23 was recorded on 04/09/25.

Levels Of Support And Resistance For NBIX Stock

The 24-hour chart illustrates a support level at 145.05, which if violated will result in even more drops to 142.82. On the upside, there is a resistance level at 149.47. A further resistance level may holdings at 151.66.

How much short interest is there in Neurocrine Biosciences, Inc?

A steep rise in short interest was recorded in Neurocrine Biosciences, Inc stocks on 2025-10-31, dropping by -0.15 million shares to a total of 4.11 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 4.26 million shares. There was a decline of -3.6%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.